ARK Genomic Revolution ETF vs Financial Select Sector SPDR Fund — how do they compare? ARK Genomic Revolution ETF trades at $44.47, while Financial Select Sector SPDR Fund trades at $57.78. Which is the better fit depends on your goals.
| ARKG | XLF | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $44.55 | $58.01 |
52-Week Low | $24.02 | $47.80 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLF trades at $57.88, up 0.12% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The ETF recently crossed above its 200-day moving average, indicating positive momentum. Recent news highlights strong inflows into sector ETFs and potential opportunities from AI infrastructure financing.
The outlook for XLF is supported by technical strength and sector tailwinds, but overbought RSI levels suggest near-term caution. Key risks include interest rate sensitivity and market volatility. Analyst sentiment is generally positive, focusing on the financial sector's role in economic growth.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →